When quality data meets pioneering GenAI for drug discovery
The new partnership between Elsevier and Iktos is set to accelerate small molecule development in pharma. See what the two main architects have to say.
![Stock photo of scientists looking at laptop screen](http://images.ctfassets.net/o78em1y1w4i4/4SiV6m48M5DhrK2nobvU0r/6b6d53a7555cfcf8105760dde133f012/header-connect-drug-discovery-image.webp?fm=webp&w=853&q=75)
Lamentablemente no somos totalmente compatibles con su navegador. Si tiene la opción, actualice a una versión más reciente o utilice Mozilla Firefox, Microsoft Edge, Google Chrome o Safari 14 o posterior. Si no puede y necesita ayuda, envíenos sus comentarios.
Agradeceríamos sus comentarios sobre esta nueva experiencia.Díganos qué piensase abre en una nueva pestaña/ventana
Discover the latest articles, resources and webinars
The new partnership between Elsevier and Iktos is set to accelerate small molecule development in pharma. See what the two main architects have to say.
Discover how research-intensive companies are navigating the perils and pitfalls of AI. Hear from experts about AI changing innovation and R&D processes to drive better business outcomes.
Watch the webinars:
Johnson Matthey on foundations for effective AIse abre en una nueva pestaña/ventana
The perils and pitfalls of generative AI for R&Dse abre en una nueva pestaña/ventana
Drug repurposing can significantly reduce timelines and cost compared with de novo drug development. Explore drug repurposing topics, including:
3 approaches to drug repurposing
Drug repurposing methods
Drug repurposing challenges
Dive into innovative methodologies, cutting-edge research and ethical considerations aimed at fostering a future without animal testing in a recorded webinar series featuring the following experts:
Successful alternatives to animal testingse abre en una nueva pestaña/ventana
Gail Van Norman, Professor Emeritus, University of Washington
Thomas Hartung, Johns Hopkins Bloomberg School of Public Health
Successful AI alternatives to animal testingse abre en una nueva pestaña/ventana
Dr. Weida Tong, FDA’s National Center for Toxicological Research
Matthew Clark, Charles River Laboratories
Medical device regulation (MDR) compliance is a challenge for medical device companies. Review key topics in MDR and access a popular webinar series to avoid errors in securing device approvals:
MDR throughout the product lifecycle
Trends and challenges in MDR
Why do regulatory submissions and applications get rejected?
MDR webinars on navigating compliance challenges and achieving certification